Targeting the tumor vasculature to enhance T cell activity.

Fiche du document

Date

2015

Types de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.coi.2015.01.011

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/25665467

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1879-0372

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_266C11B75B8F3

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer



Citer ce document

E. Lanitis et al., « Targeting the tumor vasculature to enhance T cell activity. », Serveur académique Lausannois, ID : 10.1016/j.coi.2015.01.011


Métriques


Partage / Export

Résumé 0

T cells play a critical role in tumor immune surveillance as evidenced by extensive mouse-tumor model studies as well as encouraging patient responses to adoptive T cell therapies and dendritic cell vaccines. It is well established that the interplay of tumor cells with their local cellular environment can trigger events that are immunoinhibitory to T cells. More recently it is emerging that the tumor vasculature itself constitutes an important barrier to T cells. Endothelial cells lining the vessels can suppress T cell activity, target them for destruction, and block them from gaining entry into the tumor in the first place through the deregulation of adhesion molecules. Here we review approaches to break this tumor endothelial barrier and enhance T cell activity.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en